| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 10/06/2005 | US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 10/06/2005 | US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore |
| 10/06/2005 | US20050221489 Recombinant negative strand virus rna expression systems and vaccines |
| 10/06/2005 | US20050221368 Methods for identifying RNA binding compounds |
| 10/06/2005 | US20050221284 Heteropolymer complexes and methods for their use |
| 10/06/2005 | US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 10/05/2005 | EP1581546A1 Avermectin b1 and avermectin b1 monosaccharide derivatives having an alkoxymethyl substituent in the 4''- or 4'-position |
| 10/05/2005 | EP1581258A1 Pharmaceutical formulation and a method of making same |
| 10/05/2005 | EP1581223A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 10/05/2005 | EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 10/05/2005 | CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 10/05/2005 | CN1678350A Remedy |
| 10/05/2005 | CN1678349A Compositions against chicken coccidiosis |
| 10/05/2005 | CN1678307A Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 10/05/2005 | CN1678188A Nucleic acid compositions for stimulating immune responses |
| 10/05/2005 | CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them |
| 10/05/2005 | CN1221265C Triazineon compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 10/04/2005 | US6951879 Heteroaromate OSC inhibitors |
| 10/04/2005 | US6951841 Bioavailability; side effect reduction |
| 09/29/2005 | WO2005090575A1 Glycosylation variants of ricin-like proteins |
| 09/29/2005 | WO2005090326A1 Antibiotic fki-1778 and process for producing the same |
| 09/29/2005 | US20050215772 Furanone derivatives and methods of making same |
| 09/29/2005 | US20050215593 Kaposi's sarcoma; Crohn's disease |
| 09/29/2005 | US20050215579 consisting of lung, renal, prostate, uterine, melanoma and breast tumors; cyclodextrin inclusion compounds aid solubility |
| 09/29/2005 | US20050215578 Thiadiazole compounds and use thereof |
| 09/29/2005 | US20050215532 Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| 09/29/2005 | US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 09/29/2005 | US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens |
| 09/29/2005 | CA2560636A1 Glycosylation variants of ricin-like proteins |
| 09/29/2005 | CA2559272A1 Novel peanut skin extract as a vaccine adjuvant |
| 09/29/2005 | CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 09/29/2005 | CA2538289A1 Antibiotic fki-1778 and process for producing the same |
| 09/28/2005 | EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 09/28/2005 | EP1578754A2 Antiprotozoal ring-substituted phospholipids |
| 09/28/2005 | EP1578750A2 Cationic porphyrin derivatives as antibacterial agents |
| 09/28/2005 | EP1420804A4 Methods and compositions for control of coccidiosis |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674894A Ether substituted imidazopyridines |
| 09/28/2005 | CN1220695C Inhibitors of nucleoside metabolism |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 09/27/2005 | US6949627 a purified polyclonal or monoclonal antibody which recognizes an epitope of a surface protein of a merozoite of Plasmodium falciparum; capable of inducing a resistance to the parasite so it can be used as a vaccine |
| 09/27/2005 | US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 09/27/2005 | US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators |
| 09/27/2005 | US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
| 09/22/2005 | WO2005087871A1 Process for producing mallotus philippensis colorant composition and the composition |
| 09/22/2005 | US20050209345 Lymphatic drug delivery system |
| 09/22/2005 | US20050209267 Thioether substituted imidazoquinolines |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline |
| 09/22/2005 | US20050209192 Autoimmune disorders; modulating protein kinase C activity |
| 09/22/2005 | US20050208155 New DNA polymerase inhibitors, mikanolide and dihydromikanolide |
| 09/22/2005 | US20050208079 Glucan-based vaccines |
| 09/22/2005 | US20050208068 Malaria immunogen and vaccine |
| 09/22/2005 | US20050208063 Vaccine containing a thiol protease |
| 09/21/2005 | EP1576160A2 Borrelidin-producing polyketide synthase and its use |
| 09/21/2005 | EP1294679B1 Beta-amino acid nitrile derivatives |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671393A Targeted oxidative therapeutic formulation |
| 09/15/2005 | WO2005084688A1 An injection power containing vermifuge |
| 09/15/2005 | US20050203178 N-[1-cyano-1-methyl-2-(5-chloro-2-{2,4-dichlorophenoxy-phenoxy}-ethyl]-4-trifluoromethoxybe; endo-parasites, helminthes |
| 09/15/2005 | US20050203148 A cyanobenzamide compound; pesticides; veterinary medicine |
| 09/15/2005 | US20050202548 Mammalian enzymatic polypeptide for use as tool in designing drugs which prevent and treat hypercholesterolemia, hyperlipemia, arteriosclerosis, parasitic infection, cell proliferative and vascular diseases |
| 09/14/2005 | EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/14/2005 | EP1572665A2 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 09/14/2005 | EP1572241A1 Oral pharmaceutical compositions comprising cyclosporin |
| 09/14/2005 | EP1572074A2 Stabilized synthetic immunogen delivery system |
| 09/14/2005 | EP1274445B1 Use of steroidal alkaloids to reverse multidrug resistance |
| 09/14/2005 | EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor |
| 09/14/2005 | CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/14/2005 | CN1668580A Aminoacetonitriles derivant for controlling parasite |
| 09/14/2005 | CN1668336A Drug transport and delivery system |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 09/14/2005 | CN1668288A Compounds with antiparasitic activity and medicines containing same |
| 09/14/2005 | CN1666779A Debilitating agent for highly toxic chicken coccidian and its preparation |
| 09/14/2005 | CN1218702C Malaria fewer preventing medicinal composition |
| 09/13/2005 | US6942866 Hepatitis viral protein for use in treatment of viral diseases |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050196385 Lymphocytic cells; industrial production of functional cells, pharmaceutical quality, large amounts; blood, plasma, serum from cytapheresis, frozen stock; cultured with synthetic activators phosphohalohydrin, phosphoepoxide, bisphosphonate,cytokine, interlukin; treat infection, parasites, cancer |
| 09/07/2005 | EP1569941A1 Anthelmintic and insecticidal thiohene compositions |
| 09/07/2005 | EP1569674A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 09/07/2005 | EP1569660A2 C-type lectin binding molecules, identification and uses thereof |
| 09/07/2005 | EP1569642A1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 09/07/2005 | EP1569515A2 Methods for vaccinating against malaria |
| 09/07/2005 | EP1023308B1 Inhibitors of nucleoside metabolism |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |
| 09/07/2005 | CN1665920A Liver engrafting cells, assays, and uses thereof |
| 09/07/2005 | CN1665801A Anti tubercular drug: compositions and methods |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1217577C Active substance combinations with insecticidal and acaricidal properties |
| 09/06/2005 | US6939946 Ring modified cyclic peptide analogs |
| 09/06/2005 | US6939892 Compositions for treating or preventing malaria and method of treating malaria |